Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-04-03

Clinical Trial Update: Influence of Lipid Lowering on Impaired Coronary Flow [NA]

View source ↗

Summary

A clinical trial evaluating the influence of lipid lowering on impaired coronary flow in coronary artery disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Aarhus University Hospital | Conditions: Coronary Artery Disease | NA | Status: COMPLETED